Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Exela Pharma Sciences LLC
FDA Inspection
•Exela Pharma Sciences LLC•July 18, 2019

Exela Pharma Sciences LLC – FDA Inspection, Jul 18, 2019

Record Details

This FDA Inspection record concerns Exela Pharma Sciences LLC, with an inspection on July 18, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Exela Pharma Sciences LLC
Inspection Date
July 18, 2019
Product Type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Samantha J. Bradley (FDA Associated Person)
View Company Profile

ID · 158d466d-f3a8-44b8-83e0-cf8497d372f6

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1096634
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued
Enforcement
Warning Letter

FDA Citations

7
  1. 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
  2. 21 CFR 211.188Prepared for each batch, include complete information
  3. 21 CFR 211.94(c)Containers & Closures Clean, Sterilized, Pyrogen-free
  4. 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
  5. 21 CFR 211.113(b)Procedures for sterile drug products
  6. 21 CFR 211.113(b)Validation lacking for sterile drug products
  7. 21 CFR 211.192Investigations of discrepancies, failures

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Exela Pharma Sciences LLC

13
DateClassificationOfficeProject area
November 15, 2024OAIDrug Quality Assurance
March 29, 2019VAIAtlanta District OfficeGeneric Drug Evaluation
December 19, 2018NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
September 11, 2018NAICenter for Drug Evaluation and ResearchBioresearch Monitoring
October 27, 2017Not classifiedAtlanta District Office
View all 13 other inspections on the company page
Other documents for Exela Pharma Sciences LLC
  • FDA Inspection 1256957 - 2024-11-15
  • FDA Inspection 1084304 - 2019-03-29
  • FDA Inspection 1081405 - 2018-12-19
  • FDA Inspection 1067755 - 2018-09-11
  • FDA Inspection 1032076 - 2017-10-27

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Exela Pharma Sciences LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.